Cargando…

US-labelled supply of Moderna's COVID-19 vaccine in Cananda

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233587/
http://dx.doi.org/10.1007/s40278-021-97808-1
_version_ 1783713885928292352
collection PubMed
description
format Online
Article
Text
id pubmed-8233587
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82335872021-06-28 US-labelled supply of Moderna's COVID-19 vaccine in Cananda Reactions Weekly News Item Springer International Publishing 2021-06-26 2021 /pmc/articles/PMC8233587/ http://dx.doi.org/10.1007/s40278-021-97808-1 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
US-labelled supply of Moderna's COVID-19 vaccine in Cananda
title US-labelled supply of Moderna's COVID-19 vaccine in Cananda
title_full US-labelled supply of Moderna's COVID-19 vaccine in Cananda
title_fullStr US-labelled supply of Moderna's COVID-19 vaccine in Cananda
title_full_unstemmed US-labelled supply of Moderna's COVID-19 vaccine in Cananda
title_short US-labelled supply of Moderna's COVID-19 vaccine in Cananda
title_sort us-labelled supply of moderna's covid-19 vaccine in cananda
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233587/
http://dx.doi.org/10.1007/s40278-021-97808-1